Shares in Hikma Pharmaceuticals were under pressure on Monday, down 2% after the company said its founder and major shareholder, Samih Darwazah, passed away last Friday at the age of 85.Hikma floated on the London Stock Exchange in 20105 and entered the FTSE 100 index in March 2015, replacing Tullow Oil.Darwazah founded Hikma in 1978 in Amman, Jordan, with the aim of bringing high-quality and affordable medicines to the world. With the help of his children, who joined the business in its early days, Hikma grew from a small factory in Jordan into the largest regional supplier of pharmaceuticals in the Middle East and North Africa.The company also expanded outside the MENA region, establishing successful operations in Europe and the United States. Today, it operates in around 50 countries, selling a broad range of branded generics, generic injectables, non-injectable generics and in-licensed patented products.